Levetiracetam-induced parkinsonism in a Huntington disease patient
- PMID: 16062099
- DOI: 10.1097/01.wnf.0000169732.00690.32
Levetiracetam-induced parkinsonism in a Huntington disease patient
Abstract
The authors present a man with Huntington disease who was treated with levetiracetam (Keppra) in an effort to reduce chorea. Chorea was markedly reduced, but the patient developed parkinsonism and lethargy after 6 weeks of treatment. Symptoms consisted of resting tremor, rigidity, increased dystonia, and gait difficulty. Side effects from levetiracetam resolved completely within 7 days of levetiracetam discontinuation, and chorea returned to baseline.
Comment in
-
Levetiracetam-induced Parkinsonism in a Huntington disease patient.Clin Neuropharmacol. 2006 Nov-Dec;29(6):303-4. doi: 10.1097/01.WNF.0000240946.51994.DF. Clin Neuropharmacol. 2006. PMID: 17095892 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
